Cargando…
The Role of Stereotactic Radiotherapy in the Management of Melanoma, A Retrospective Single Institute Preliminary Study of 30 Patients
Cutaneous melanoma is the third most common type of skin cancer in the world. The incidence of melanoma is increasing in most countries, however, mortality seems to be slowly decreasing. The treatment of advanced cutaneous melanoma changed radically since 2011. The new therapeutic modalities, such a...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9492835/ https://www.ncbi.nlm.nih.gov/pubmed/36157171 http://dx.doi.org/10.3389/pore.2022.1610550 |
_version_ | 1784793562775289856 |
---|---|
author | Kispál, Mihály Jánváry, Levente Zsolt Balatoni, Tímea Gábor, Stelczer Fedorcsák, Imre Katalin, Bőcs Kenessey, István Liszkay, Gabriella |
author_facet | Kispál, Mihály Jánváry, Levente Zsolt Balatoni, Tímea Gábor, Stelczer Fedorcsák, Imre Katalin, Bőcs Kenessey, István Liszkay, Gabriella |
author_sort | Kispál, Mihály |
collection | PubMed |
description | Cutaneous melanoma is the third most common type of skin cancer in the world. The incidence of melanoma is increasing in most countries, however, mortality seems to be slowly decreasing. The treatment of advanced cutaneous melanoma changed radically since 2011. The new therapeutic modalities, such as immuno- and targeted therapies give a chance to successfully reach more prolonged progression-free survival (PFS) and overall survival (OS) in patients with metastatic melanoma. Despite the great therapeutic benefit, most patients eventually develop resistance to these therapies, and the disease will progress. In some cases oligoprogression develops. In those cases local therapy, such as stereotactic radiotherapy can make it possible to continue the previously applied effective medical treatment for the benefit of patients. In our study of a total of 30 patients—20 of them received pre-treatment with systemic medical therapy—received stereotactic radiotherapy using various systems, in the National Institute of Oncology, Hungary, Budapest. We managed to prolong the systemic therapy for 12.5 months median period with the assistance of CyberKnife technique. Therapy related adverse events were mostly tolerable with only 3% of Grade 3 toxicity. We concluded that stereotactic radiotherapy and stereotactic radiosurgery, are safe, and effective therapeutic modalities for regional tumor control in cases of oligoprogression. |
format | Online Article Text |
id | pubmed-9492835 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-94928352022-09-23 The Role of Stereotactic Radiotherapy in the Management of Melanoma, A Retrospective Single Institute Preliminary Study of 30 Patients Kispál, Mihály Jánváry, Levente Zsolt Balatoni, Tímea Gábor, Stelczer Fedorcsák, Imre Katalin, Bőcs Kenessey, István Liszkay, Gabriella Pathol Oncol Res Pathology and Oncology Archive Cutaneous melanoma is the third most common type of skin cancer in the world. The incidence of melanoma is increasing in most countries, however, mortality seems to be slowly decreasing. The treatment of advanced cutaneous melanoma changed radically since 2011. The new therapeutic modalities, such as immuno- and targeted therapies give a chance to successfully reach more prolonged progression-free survival (PFS) and overall survival (OS) in patients with metastatic melanoma. Despite the great therapeutic benefit, most patients eventually develop resistance to these therapies, and the disease will progress. In some cases oligoprogression develops. In those cases local therapy, such as stereotactic radiotherapy can make it possible to continue the previously applied effective medical treatment for the benefit of patients. In our study of a total of 30 patients—20 of them received pre-treatment with systemic medical therapy—received stereotactic radiotherapy using various systems, in the National Institute of Oncology, Hungary, Budapest. We managed to prolong the systemic therapy for 12.5 months median period with the assistance of CyberKnife technique. Therapy related adverse events were mostly tolerable with only 3% of Grade 3 toxicity. We concluded that stereotactic radiotherapy and stereotactic radiosurgery, are safe, and effective therapeutic modalities for regional tumor control in cases of oligoprogression. Frontiers Media S.A. 2022-09-08 /pmc/articles/PMC9492835/ /pubmed/36157171 http://dx.doi.org/10.3389/pore.2022.1610550 Text en Copyright © 2022 Kispál, Jánváry, Balatoni, Gábor, Fedorcsák, Katalin, Kenessey and Liszkay. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Pathology and Oncology Archive Kispál, Mihály Jánváry, Levente Zsolt Balatoni, Tímea Gábor, Stelczer Fedorcsák, Imre Katalin, Bőcs Kenessey, István Liszkay, Gabriella The Role of Stereotactic Radiotherapy in the Management of Melanoma, A Retrospective Single Institute Preliminary Study of 30 Patients |
title | The Role of Stereotactic Radiotherapy in the Management of Melanoma, A Retrospective Single Institute Preliminary Study of 30 Patients |
title_full | The Role of Stereotactic Radiotherapy in the Management of Melanoma, A Retrospective Single Institute Preliminary Study of 30 Patients |
title_fullStr | The Role of Stereotactic Radiotherapy in the Management of Melanoma, A Retrospective Single Institute Preliminary Study of 30 Patients |
title_full_unstemmed | The Role of Stereotactic Radiotherapy in the Management of Melanoma, A Retrospective Single Institute Preliminary Study of 30 Patients |
title_short | The Role of Stereotactic Radiotherapy in the Management of Melanoma, A Retrospective Single Institute Preliminary Study of 30 Patients |
title_sort | role of stereotactic radiotherapy in the management of melanoma, a retrospective single institute preliminary study of 30 patients |
topic | Pathology and Oncology Archive |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9492835/ https://www.ncbi.nlm.nih.gov/pubmed/36157171 http://dx.doi.org/10.3389/pore.2022.1610550 |
work_keys_str_mv | AT kispalmihaly theroleofstereotacticradiotherapyinthemanagementofmelanomaaretrospectivesingleinstitutepreliminarystudyof30patients AT janvaryleventezsolt theroleofstereotacticradiotherapyinthemanagementofmelanomaaretrospectivesingleinstitutepreliminarystudyof30patients AT balatonitimea theroleofstereotacticradiotherapyinthemanagementofmelanomaaretrospectivesingleinstitutepreliminarystudyof30patients AT gaborstelczer theroleofstereotacticradiotherapyinthemanagementofmelanomaaretrospectivesingleinstitutepreliminarystudyof30patients AT fedorcsakimre theroleofstereotacticradiotherapyinthemanagementofmelanomaaretrospectivesingleinstitutepreliminarystudyof30patients AT katalinbocs theroleofstereotacticradiotherapyinthemanagementofmelanomaaretrospectivesingleinstitutepreliminarystudyof30patients AT kenesseyistvan theroleofstereotacticradiotherapyinthemanagementofmelanomaaretrospectivesingleinstitutepreliminarystudyof30patients AT liszkaygabriella theroleofstereotacticradiotherapyinthemanagementofmelanomaaretrospectivesingleinstitutepreliminarystudyof30patients AT kispalmihaly roleofstereotacticradiotherapyinthemanagementofmelanomaaretrospectivesingleinstitutepreliminarystudyof30patients AT janvaryleventezsolt roleofstereotacticradiotherapyinthemanagementofmelanomaaretrospectivesingleinstitutepreliminarystudyof30patients AT balatonitimea roleofstereotacticradiotherapyinthemanagementofmelanomaaretrospectivesingleinstitutepreliminarystudyof30patients AT gaborstelczer roleofstereotacticradiotherapyinthemanagementofmelanomaaretrospectivesingleinstitutepreliminarystudyof30patients AT fedorcsakimre roleofstereotacticradiotherapyinthemanagementofmelanomaaretrospectivesingleinstitutepreliminarystudyof30patients AT katalinbocs roleofstereotacticradiotherapyinthemanagementofmelanomaaretrospectivesingleinstitutepreliminarystudyof30patients AT kenesseyistvan roleofstereotacticradiotherapyinthemanagementofmelanomaaretrospectivesingleinstitutepreliminarystudyof30patients AT liszkaygabriella roleofstereotacticradiotherapyinthemanagementofmelanomaaretrospectivesingleinstitutepreliminarystudyof30patients |